InvestorsHub Logo
Followers 56
Posts 14300
Boards Moderated 0
Alias Born 01/19/2009

Re: Ubertino post# 136166

Friday, 11/17/2017 12:20:16 PM

Friday, November 17, 2017 12:20:16 PM

Post# of 146194

Management believes that the Company’s existing cash resources are sufficient for its operations at the current rate of expenditures to continue through November 2018. However, management believes that the available funds are insufficient for the Company’s projected work, which is beyond normal pre-clinical development operations, leading towards an Investigational New Drug Application (IND) filing with the U.S. Food and Drug Administration (FDA), to continue through November 2018.
p.10 https://ih.advfn.com/p.php?pid=nmona&article=76095857




Right from the horse's mouth: No money, no IND, nothing.

A casual stroll through the lunatic asylum shows that faith does not prove anything. Friedrich Nietzsche

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News